金沙8888js官方(中國)官方網站-App Platform
Skip to content
服务内容
产品服务概述
GLG 服务入门使用指南
GLG 学院
专家访谈
电话访谈
人才服务
研究服务
定量研究
定制洞察
定性研究
前沿洞见
专家洞见
会议活动
会议纪要资料库
客户行业
企业客户
科技行业
医疗器械、诊断和生命科学
制药和生物技术行业
工业企业
消费品行业
支付与保险行业
金融服务
对冲基金
私募股权投资
信贷业务
投资经理人和公募基金
投资银行及研究
专业服务
咨询公司服务
广告和公关咨询
专家团成员
职业发展
社会影响力项目
合规框架
关于我们
关于我们
新闻
常见问题解答
公司简介
公司历史
联系我们
登录
客户登录 - MyGLG
客户合规人士
专家团成员
English
简体中文
日本語
한국어
Deutsch
Menu
专家洞见
GLG的专家团拥有约 100 万名成员,涵盖所有主要行业与地区的意见领袖。
在此可浏览部分专家的观点。
按洞见类型 全部
全部
文章
案例研究
视频
白皮书
播客
No Search Results
文章
Digital Health Platforms Buy and Build
Healthcare and Life Sciences
文章
The State of Pharma Contract Development and Manufacturing Organizations
CDMO
,
Pharmaceutical Industry
,
Healthcare and Life Sciences
文章
What We Can Do about Wasted Pharmaceuticals
Pharmaceutical Industry
,
Healthcare and Life Sciences
文章
Challenges and Opportunities in Australia’s Radiology Industry
Radiology
,
Healthcare and Life Sciences
文章
The Inflation Reduction Act: What Drugmakers Should Know
Pharmaceutical Industry
,
Global Politics
,
Healthcare and Life Sciences
文章
Looking at the Australian National Disability Insurance Scheme (NDIS)
Australia
,
Healthcare and Life Sciences
文章
At-Home Healthcare After COVID-19
Coronavirus
,
Healthcare and Life Sciences
文章
TPP Testing in Pharma: Best Practices
Pharmaceutical Industry
,
TPP
,
Healthcare and Life Sciences
文章
Drilling into Dental Industry Trends
Coronavirus
,
Dental Services
,
Dentists
,
Healthcare and Life Sciences
文章
Radiation Oncology Market: The Battle for Doctors
Oncology
,
Radiology
,
Healthcare and Life Sciences
文章
GLG Institute’s “Effective Leadership Development in a Post-COVID World” roundtable highlights
Coronavirus
,
Leadership
,
Healthcare and Life Sciences
文章
Analyzing Australia’s Response to COVID-19
Australia
,
Coronavirus
,
Global Politics
,
Healthcare and Life Sciences
文章
Report: Illuminating Invisible Inequities in Healthcare
Healthcare and Life Sciences
,
Social Impact
文章
Biogen’s Aduhelm: An Update on the Commercial Rollout
Alzheimer’s
,
Biogen
,
Pharmaceutical Industry
,
Healthcare and Life Sciences
文章
FDA’s Controversial Aduhelm Approval: What Happens Next?
Alzheimer’s
,
Biogen
,
Pharmaceutical Industry
,
Healthcare and Life Sciences
文章
The Future of Healthcare in India
India
,
Telemedicine
,
Healthcare and Life Sciences
文章
Professor Lawrence Gostin on Mask and Vaccine Mandates
Coronavirus
,
Healthcare and Life Sciences
文章
Why the FDA Was Correct in Approving Biogen’s Aducanumab
Alzheimer’s
,
Health Care
,
Healthcare and Life Sciences
文章
Insights from GLG Institute’s 2021 Healthcare Leadership Summit
Boardroom
,
Corporate Responsibility
,
Innovation
,
Leadership
,
Healthcare and Life Sciences
文章
Jeb Bush and Martin O’Malley on Reopening After COVID-19
Policy
,
U.S. Politics
,
Global Politics
,
Healthcare and Life Sciences
文章
COVID Vaccinations in Hong Kong: An Update
Coronavirus
,
Vaccines
,
Healthcare and Life Sciences
文章
COVID Vaccinations in Hong Kong: Q and A
Coronavirus
,
Vaccines
,
Healthcare and Life Sciences
文章
Biden’s Healthcare Priorities
Biden
,
Coronavirus
,
U.S. Politics
,
Vaccines
,
Global Politics
,
Healthcare and Life Sciences
文章
Updates on COVID-19: New Variants and Vaccination Campaigns
Coronavirus
,
Vaccines
,
Healthcare and Life Sciences
文章
An Overview of Southeast Asian Healthcare Delivery
HMO
,
Primary Care
,
Healthcare and Life Sciences
文章
Obamacare Likely to Be Safe from Supreme Court, Kathleen Sebelius Says
Affordable Care Act
,
Obamacare
,
Supreme Court.
,
Healthcare and Life Sciences
文章
Kathleen Sebelius: ‘Trickle-Down Chaos’ Led to Poor COVID Response
Coronavirus
,
Vaccines
,
Healthcare and Life Sciences
文章
The Future of Digital Health in India
Coronavirus
,
Healthcare and Life Sciences
文章
Healthcare Leadership: 3 Takeaways from 2020
industry insights
,
Healthcare and Life Sciences
文章
Covid-19 Vaccines and Therapeutics: Where We Stand Now
Coronavirus
,
Therapeutics
,
Vaccines
,
Healthcare and Life Sciences
文章
Is Asian Healthcare on the Verge of a Digital Revolution?
Technology
,
Telemedicine
,
Healthcare and Life Sciences
文章
J.P. Morgan Healthcare 2021: How to Make the Most of This Year’s Virtual Conference
Conferences
,
J.P. Morgan
,
Healthcare and Life Sciences
文章
The 2021 Physician Staffing Outlook
Coronavirus
,
Physicians
,
Staffing
,
Healthcare and Life Sciences
文章
The Nutraceuticals Market Is Booming. Will It Last?
Consumer Packaged Goods
,
Nutraceuticals
,
Healthcare and Life Sciences
文章
Ebook: The Rise of Telemedicine: Survey and Perspectives
Ebook
,
Telemedicine
,
Healthcare and Life Sciences
文章
The Future of the ACA in a Post-Ginsburg World
Affordable Care Act
,
Supreme Court.
,
U.S. Politics
,
Global Politics
,
Healthcare and Life Sciences
文章
COVID-19 Vaccine Update: The Global Connection and Public Health Issues
Coronavirus
,
Vaccines
,
Healthcare and Life Sciences
文章
COVID-19 Update: The Race for a Vaccine
Coronavirus
,
Vaccines
,
Healthcare and Life Sciences
文章
Is the Fertility Solutions Space Due for a Recovery Soon?
Femtech
,
Technology
,
Healthcare and Life Sciences
文章
Huge Growth Potential in Femtech and Maternal Services
Femtech
,
Technology
,
Healthcare and Life Sciences
文章
Telemedicine Survey: Patient and Physician Adoption
Survey
,
Telemedicine
,
Healthcare and Life Sciences
文章
Women Want Menopause Solutions. Will Companies Meet the Need?
Femtech
,
Technology
,
Healthcare and Life Sciences
文章
Telemedicine Dynamics: Regulatory Perspective
Telemedicine
,
Healthcare and Life Sciences
文章
What Does K-12 School Reopening Look Like for Students?
Coronavirus
,
Education Industry
,
K-12
,
New Normal
,
Healthcare and Life Sciences
文章
Telemedicine Dynamics: Payer Perspective
Payers
,
Telemedicine
,
Healthcare and Life Sciences
文章
COVID-19 Vaccines: Moderna, Pfizer/BioNTech, AstraZeneca/Oxford
Coronavirus
,
Vaccines
,
Healthcare and Life Sciences
文章
A Look at Moderna’s SARS-CoV-2 Vaccine
Coronavirus
,
Healthcare and Life Sciences
文章
The Cast Is Coming Off for the Orthopedics Field to Make a Full Recovery
Coronavirus
,
Healthcare and Life Sciences
文章
Dermatology’s COVID-19 Problems Are Deep and Will Take Time to Heal
Coronavirus
,
Healthcare and Life Sciences
文章
COVID-19 May Have Blurred the Ophthalmology Sector, but Recovery Is a Few Blinks Away
Coronavirus
,
Healthcare and Life Sciences
文章
COVID-19 and Public Perception
Coronavirus
,
Healthcare and Life Sciences
文章
A Quick Take on STAT’s Remdesivir April 16 Reporting
Coronavirus
,
Healthcare and Life Sciences
文章
How Prepared Are Hospitals for the Surge of COVID-19 Patients?
Coronavirus
,
Healthcare and Life Sciences
文章
Shelter-in-Place May Not Be Enough to Fight COVID-19, Says Former CDC Doctor
Coronavirus
,
Healthcare and Life Sciences
文章
Where We Are in the Global Response to COVID-19
Coronavirus
,
Healthcare and Life Sciences
文章
COVID-19: A Former City Health Commissioner’s Perspective
Coronavirus
,
Healthcare and Life Sciences
文章
What Will It Take to Develop a Vaccine for the Virus that Causes COVID-19?
Coronavirus
,
Healthcare and Life Sciences
文章
How Will COVID-19 Affect the Business of U.S. Hospitals?
Coronavirus
,
Healthcare and Life Sciences
文章
COVID-19: What We Know So Far February 25
Coronavirus
,
Healthcare and Life Sciences
文章
Assessing the COVID-19 Outbreak Jan 31
Coronavirus
,
Healthcare and Life Sciences
订阅 GLG 洞见趋势月度专栏
输入您的电子邮件,接收我们的月度通讯,获取来自全球约 100 万名 GLG 专家团成员的专业洞见。
XML 地图